2-oxindole has been researched along with Brain Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alipanah, R; Chong, S; Delgado, C; Hoa, N; Jadus, MR; Jeffes, EW; Khalaghizadeh, S; Khomenko, T; Knight, BA; Liu, J; Nguyen, TV; Obenaus, A; Petkar, A; Sanchez, R; Shah, C; Vohra, S; Wepsic, HT; Zhang, JG; Zhuang, JL | 1 |
1 other study(ies) available for 2-oxindole and Brain Neoplasms
| Article | Year |
|---|---|
Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cancer Vaccines; Cell Line, Tumor; Cells, Cultured; Drug Synergism; Endothelial Cells; Female; Glioma; Growth Inhibitors; Immunohistochemistry; Indoles; Injections, Intraperitoneal; Interleukin-2; Lymphocytes, Tumor-Infiltrating; Macrophage Colony-Stimulating Factor; Magnetic Resonance Imaging; Membrane Proteins; Oxindoles; Rats; Rats, Inbred F344; Receptors, Growth Factor; RNA, Messenger; Spleen | 2005 |